Ibotenic Acid
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 561191

CAS#: 2552-55-8

Description: Ibotenic Acid is a potent excitatory amino acid agonist. Ibotenic Acid causes motor depression, ataxia, and changes in mood. Ibotenic Acid is also a neurotoxin.


Chemical Structure

img
Ibotenic Acid
CAS# 2552-55-8

Theoretical Analysis

MedKoo Cat#: 561191
Name: Ibotenic Acid
CAS#: 2552-55-8
Chemical Formula: C5H6N2O4
Exact Mass: 158.0328
Molecular Weight: 158.11
Elemental Analysis: C, 37.98; H, 3.83; N, 17.72; O, 40.47

Size Price Shipping out time Quantity
5mg USD 360 2 Weeks
25mg USD 1000 2 Weeks
Inquire bulk and customized quantity

Pricing updated 2021-03-04. Prices are subject to change without notice.

Ibotenic Acid, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received

Synonym: Ibotenic Acid; Ibotenate

IUPAC/Chemical Name: 2-Amino-2-(3-oxo-1,2-oxazol-5-yl)acetic acid

InChi Key: IRJCBFDCFXCWGO-UHFFFAOYSA-N

InChi Code: InChI=1S/C5H6N2O4/c6-4(5(9)10)2-1-3(8)7-11-2/h1,4H,6H2,(H,7,8)(H,9,10)

SMILES Code: O=C(O)C(N)C(ON1)=CC1=O

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001

Handling Instructions:

Preparing Stock Solutions

The following data is based on the product molecular weight 158.11 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Stebelska K. Fungal hallucinogens psilocin, ibotenic acid, and muscimol: analytical methods and biologic activities. Ther Drug Monit. 2013 Aug;35(4):420-42. doi: 10.1097/FTD.0b013e31828741a5. Review. PubMed PMID: 23851905.

2: Krogsgaard-Larsen P, Honoré T, Hansen JJ, Curtis DR, Lodge D. Structure-activity studies on ibotenic acid and related muscimol analogues. Adv Biochem Psychopharmacol. 1981;27:285-94. Review. PubMed PMID: 7004116.

3: Dunnett SB, Isacson O, Sirinathsinghji DJ, Clarke DJ, Björklund A. Striatal grafts in the ibotenic acid-lesioned neostriatum: functional studies. Prog Brain Res. 1988;78:39-45. Review. PubMed PMID: 3073422.

4: Gressens P, Marret S, Evrard P. Developmental spectrum of the excitotoxic cascade induced by ibotenate: a model of hypoxic insults in fetuses and neonates. Neuropathol Appl Neurobiol. 1996 Dec;22(6):498-502. Review. PubMed PMID: 9004236.

5: Iseki S. [Clinical toxicology of mushroom poisoning. Amanita pantherina, Amanita ibotengutake]. Chudoku Kenkyu. 2013 Sep;26(3):219-22. Review. Japanese. PubMed PMID: 24224385.

6: Luhmann HJ. Models of cortical malformation--Chemical and physical. J Neurosci Methods. 2016 Feb 15;260:62-72. doi: 10.1016/j.jneumeth.2015.03.034. Epub 2015 Apr 4. Review. PubMed PMID: 25850077.

7: Jhamandas KH, Boegman RJ, Beninger RJ. The 1993 Upjohn Award Lecture. Quinolinic acid induced brain neurotransmitter deficits: modulation by endogenous excitotoxin antagonists. Can J Physiol Pharmacol. 1994 Dec;72(12):1473-82. Review. PubMed PMID: 7736338.

8: Hansen JJ, Krogsgaard-Larsen P. Structural, conformational, and stereochemical requirements of central excitatory amino acid receptors. Med Res Rev. 1990 Jan-Mar;10(1):55-94. Review. PubMed PMID: 2153264.

9: Takeuchi H. Sensitivities of Achatina giant neurones to putative amino acid neurotransmitters. Comp Biochem Physiol C. 1992 Sep;103(1):1-12. Review. PubMed PMID: 1360362.

10: Yoneda Y. [Receptive mechanisms of excitatory amino acid signals]. Yakugaku Zasshi. 1993 Jul;113(7):469-88. Review. Japanese. PubMed PMID: 7690072.

11: Krogsgaard-Larsen P, Wahl P, Schousboe A, Madsen U, Hansen JJ. Excitatory amino acid research in Alzheimer's disease: enhancement and blockade of receptor functions. Biochem Soc Trans. 1993 Feb;21(1):102-6. Review. PubMed PMID: 7680619.

12: Kaneko I, Kubo T, Morimoto K. [Neurotoxicity of beta-amyloid]. Nihon Yakurigaku Zasshi. 2000 Feb;115(2):67-77. Review. Japanese. PubMed PMID: 10876793.

13: Krogsgaard-Larsen P, Hansen JJ. Naturally-occurring excitatory amino acids as neurotoxins and leads in drug design. Toxicol Lett. 1992 Dec;64-65 Spec No:409-16. Review. PubMed PMID: 1335179.

14: Dunnett SB, Everitt BJ, Robbins TW. The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions. Trends Neurosci. 1991 Nov;14(11):494-501. Review. PubMed PMID: 1726766.

15: Rasia-Filho AA, Haas D, de Oliveira AP, de Castilhos J, Frey R, Stein D, Lazzari VM, Back F, Pires GN, Pavesi E, Winkelmann-Duarte EC, Giovenardi M. Morphological and functional features of the sex steroid-responsive posterodorsal medial amygdala of adult rats. Mini Rev Med Chem. 2012 Oct;12(11):1090-106. Review. PubMed PMID: 22827219.

16: Šaponjić J. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms]. Glas Srp Akad Nauka Med. 2011;(51):85-97. Review. Serbian. PubMed PMID: 22165729.

17: Robbins TW, Everitt BJ. Comparative functions of the central noradrenergic, dopaminergic and cholinergic systems. Neuropharmacology. 1987 Jul;26(7B):893-901. Review. PubMed PMID: 3116447.

18: Halpern JH. Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther. 2004 May;102(2):131-8. Review. PubMed PMID: 15163594.

19: Coote JH. Cardiovascular function of the paraventricular nucleus of the hypothalamus. Biol Signals. 1995 May-Jun;4(3):142-9. Review. PubMed PMID: 8750940.

20: Schliebs R, Rossner S, Bigl V. Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: a useful tool to produce cortical cholinergic dysfunction. Prog Brain Res. 1996;109:253-64. Review. PubMed PMID: 9009714.